357 related articles for article (PubMed ID: 31956375)
1. Identification of a Sixteen-gene Prognostic Biomarker for Lung Adenocarcinoma Using a Machine Learning Method.
Ma B; Geng Y; Meng F; Yan G; Song F
J Cancer; 2020; 11(5):1288-1298. PubMed ID: 31956375
[No Abstract] [Full Text] [Related]
2. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
3. A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma.
Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
PeerJ; 2020; 8():e10008. PubMed ID: 33024640
[TBL] [Abstract][Full Text] [Related]
4. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
Mi K; Zeng L; Chen Y; Yang S
Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
7. Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods.
Cai Q; He B; Zhang P; Zhao Z; Peng X; Zhang Y; Xie H; Wang X
J Transl Med; 2020 Dec; 18(1):463. PubMed ID: 33287830
[TBL] [Abstract][Full Text] [Related]
8. Construction of a prognostic model for lung adenocarcinoma based on bioinformatics analysis of metabolic genes.
He J; Li W; Li Y; Liu G
Transl Cancer Res; 2020 May; 9(5):3518-3538. PubMed ID: 35117717
[TBL] [Abstract][Full Text] [Related]
9. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
Front Genet; 2022; 13():833797. PubMed ID: 35154287
[No Abstract] [Full Text] [Related]
10. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
11. Development of a RNA-Seq Based Prognostic Signature in Lung Adenocarcinoma.
Shukla S; Evans JR; Malik R; Feng FY; Dhanasekaran SM; Cao X; Chen G; Beer DG; Jiang H; Chinnaiyan AM
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27707839
[TBL] [Abstract][Full Text] [Related]
12. Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning.
Wang Q; Sun N; Zhang M
Int J Gen Med; 2023; 16():1833-1844. PubMed ID: 37213475
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel embryonic germline gene-related prognostic model of lung adenocarcinoma.
Liu L; Xu K; Zhou Y
PeerJ; 2021; 9():e12257. PubMed ID: 34721973
[TBL] [Abstract][Full Text] [Related]
14. A Recurrence-Specific Gene-Based Prognosis Prediction Model for Lung Adenocarcinoma through Machine Learning Algorithm.
Xu S; Zhou J; Liu K; Chen Z; He Z
Biomed Res Int; 2020; 2020():9124792. PubMed ID: 33224985
[TBL] [Abstract][Full Text] [Related]
15. Identification of ceRNA network based on a RNA-seq shows prognostic lncRNA biomarkers in human lung adenocarcinoma.
Li X; Li B; Ran P; Wang L
Oncol Lett; 2018 Nov; 16(5):5697-5708. PubMed ID: 30344725
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance.
Zhou E; Wu F; Guo M; Yin Z; Li Y; Li M; Xia H; Deng J; Yang G; Jin Y
Front Oncol; 2022; 12():1008283. PubMed ID: 36530971
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a 12-Gene Immune Relevant Prognostic Signature for Lung Adenocarcinoma Through Machine Learning Strategies.
Xue L; Bi G; Zhan C; Zhang Y; Yuan Y; Fan H
Front Oncol; 2020; 10():835. PubMed ID: 32537435
[No Abstract] [Full Text] [Related]
18. Identification of seven-gene marker to predict the survival of patients with lung adenocarcinoma using integrated multi-omics data analysis.
Zhang S; Zeng X; Lin S; Liang M; Huang H
J Clin Lab Anal; 2022 Feb; 36(2):e24190. PubMed ID: 34951053
[TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma.
Wu M; Wu Z; Yan J; Zeng J; Kuang J; Zhong C; Zhu X; Mo Y; Guo Q; Li D; Tan J; Zhang T; Zhang J
Front Oncol; 2023; 13():1198746. PubMed ID: 37427142
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]